Biocon's Kiran Mazumdar-Shaw Admits CDMO Unit 'Strayed From Core Strength', Pledges Rebuild

Founder's rare public concession of strategic misstep at Biocon Biologics' CDMO arm signals course-correction after Viatris acquisition debt and integration strains hit capacity utilisation.

ndtv-profit-business · 7/14/2026, 4:46:48 AM · Ask about this →